Men's Health News

RSS

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Tapping into the Million Veteran Program, an ongoing national research effort to learn how genes, lifestyle and military exposures affect the health of participants, researchers at University of California San Diego School of Medicine and the VA San Diego Healthcare System, with colleagues elsewhere, report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer.

31 Oct 2022

Psychosocial impact on pandemic workers in Shanghai during Omicron wave lockdown

In a recent study posted to the medRxiv* server, researchers assessed the well-being of all workers involved in coronavirus disease 2019 (COVID-19) testing between April and June 2022, i.e., during the Omicron wave lockdown in Shanghai, China.

30 Oct 2022

How COVID-19 impacted sleep and mental health among university students

In a recent study published in the journal PLoS ONE, researchers evaluated the effects of coronavirus disease 2019 (COVID-19) on the sleep quality and mental health (MH) of university-attending undergraduate students.

30 Oct 2022

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

In a recent study published in the journal JAMA Network Open, researchers in the United States estimated the sociodemographic factors associated with and prevalence of post-acute coronavirus disease 2019 (COVID-19) symptom sequelae (PASC) or long COVID (LCOVID).

30 Oct 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

Long COVID, a new clinical entity constantly evolving

Researchers discuss the epidemiology, diagnosis, pathogenesis, and treatment of long COVID.

27 Oct 2022

In mild cases of COVID, blood clot risk is higher

Researchers examine the association between COVID-19 and increased cardiovascular outcomes and mortality sequelae.

27 Oct 2022

New initiative to improve HIV health outcomes for Black men who have sex with men

The results of a multi-year initiative aimed at improving HIV health outcomes for Black men who have sex with men (MSM) are published in a new Supplement in the peer-reviewed journal AIDS Patient Care and STDs.

27 Oct 2022

Research reveals molecular pathways of aggressive cribriform prostate cancer

Cribriform prostate cancer is an aggressive subtype of the disease characterized by its histology, but little is known about its molecular pathways.

26 Oct 2022

Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free survival (PFS) in patients with oligometastatic prostate cancer.

25 Oct 2022

Study offers a combination treatment option for patients with oligometastatic prostate cancer

A new study offers a new option to patients with oligometastatic prostate cancer who want relief from hormone therapy without compromising the risk of their disease spreading.

25 Oct 2022

More intensive prostate cancer screening may reduce the risk of metastatic cancer later

In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a large, longitudinal analysis found Veterans Health Administration medical centers with lower prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years than centers with higher screening rates.

24 Oct 2022

Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy.

24 Oct 2022

Sexual side effects of cancer treatment discussed less frequently with female patients

A new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.

24 Oct 2022

An analysis of excess mortality rates during COVID-19 pandemic in countries with aging populations

Researchers explore the association between excess mortality and various factors before and during the COVID-19 pandemic.

23 Oct 2022

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Researchers examine neutralizing antibody responses against SARS-CoV-2 in elderly individuals who received one mRNA booster dose.

23 Oct 2022

How does COVID-19 and its treatment affect testicular function?

Researchers summarized available information related to the reproductive effects of COVID-19 in men.

23 Oct 2022

Cedars Sinai experts remind men of their breast cancer risk

Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.

21 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

Men's Health News

COVID-19 pandemic increased deaths and disease caused by tuberculosis

Polygenic hazard score could be effective for predicting genetic risk of lethal prostate cancer

Psychosocial impact on pandemic workers in Shanghai during Omicron wave lockdown

How COVID-19 impacted sleep and mental health among university students

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

Standard cutoff point for low testosterone levels may not be accurate for young men

Long COVID, a new clinical entity constantly evolving

In mild cases of COVID, blood clot risk is higher

New initiative to improve HIV health outcomes for Black men who have sex with men

Research reveals molecular pathways of aggressive cribriform prostate cancer

Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer

Study offers a combination treatment option for patients with oligometastatic prostate cancer

More intensive prostate cancer screening may reduce the risk of metastatic cancer later

Clinical trial confirms the safety, efficacy of shortened radiation therapy for high-risk prostate cancer patients

Sexual side effects of cancer treatment discussed less frequently with female patients

An analysis of excess mortality rates during COVID-19 pandemic in countries with aging populations

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

How does COVID-19 and its treatment affect testicular function?

Cedars Sinai experts remind men of their breast cancer risk

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News